Mortality and re-revision following single-stage and two-stage revision surgery for the management of infected primary hip arthroplasty in England and Wales

Author:

Lenguerrand Erik1ORCID,Whitehouse Michael R.12,Beswick Andrew D.1,Kunutsor Setor K.12,Webb Jason C. J.3,Mehendale Sanchit4,Porter Martyn5,Blom Ashley W.12

Affiliation:

1. Musculoskeletal Research Unit, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK

2. National Institute for Health Research Bristol Biomedical Research Centre, University Hospitals Bristol NHS Foundation Trust and University of Bristol, Bristol, UK

3. Avon Orthopaedic Centre, Southmead Hospital, North Bristol NHS Trust, Bristol, UK

4. Department of Trauma and Orthopaedics, Bristol Royal Infirmary, Bristol, UK

5. Centre for Hip Surgery, Wrightington Hospital, Wrightington, UK

Abstract

AimsWe compared the risks of re-revision and mortality between two-stage and single-stage revision surgeries among patients with infected primary hip arthroplasty.MethodsPatients with a periprosthetic joint infection (PJI) of their primary arthroplasty revised with single-stage or two-stage procedure in England and Wales between 2003 and 2014 were identified from the National Joint Registry. We used Poisson regression with restricted cubic splines to compute hazard ratios (HRs) at different postoperative periods. The total number of revisions and re-revisions undergone by patients was compared between the two strategies.ResultsIn total, 535 primary hip arthroplasties were revised with single-stage procedure (1,525 person-years) and 1,605 with two-stage procedure (5,885 person-years). All-cause re-revision was higher following single-stage revision, especially in the first three months (HR at 3 months = 1.98 (95% confidence interval (CI) 1.14 to 3.43), p = 0.009). The risks were comparable thereafter. Re-revision for PJI was higher in the first three postoperative months for single-stage revision and waned with time (HR at 3 months = 1.81 (95% CI 1.22 to 2.68), p = 0.003; HR at 6 months = 1.25 (95% CI 0.71 to 2.21), p = 0.441; HR at 12 months = 0.94 (95% CI 0.54 to 1.63), p = 0.819). Patients initially managed with a single-stage revision received fewer revision operations (mean 1.3 (SD 0.7) vs 2.2 (SD 0.6), p < 0.001). Mortality rates were comparable between these two procedures (29/10,000 person-years vs 33/10,000).ConclusionThe risk of unplanned re-revision was lower following two-stage revision, but only in the early postoperative period. The lower overall number of revision procedures associated with a single-stage revision strategy and the equivalent mortality rates to two-stage revision are reassuring. With appropriate counselling, single-stage revision is a viable option for the treatment of hip PJI.Cite this article: Bone Joint Res 2023;12(5):321–330.

Publisher

British Editorial Society of Bone & Joint Surgery

Subject

Orthopedics and Sports Medicine,Surgery

Reference46 articles.

1. How long does A hip replacement last? A systematic review and meta-analysis of case series and national registry reports with more than 15 years of follow-up;Evans;Lancet,2019

2. Revision for prosthetic joint infection following hip arthroplasty: Evidence from the National Joint Registry;Lenguerrand;Bone Joint Res,2017

3. The incidence of late prosthetic joint infections: a registry-based study of 112,708 primary hip and knee replacements;Huotari;Acta Orthop,2015

4. The lifetime risk of revision following total hip arthroplasty;Nugent;Bone Joint J,2021

5. W-Dahl A , Kärrholm J , Rogmark C , et al. Annual report 2021 . The Swedish Arthroplasty Register . 2021 . https://registercentrum.blob.core.windows.net/slr/r/SAR-Annual-Report-2021-SJlAFmlRl5.pdf ( date last accessed 21 April 2023 ).

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Artificial intelligence in orthopaedics;Bone & Joint Research;2023-08-09

2. Hip & Pelvis;Bone & Joint 360;2023-08-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3